Skip to main content Back to Top
Advertisement

9/11/2018

Atenolol tablets

Products Affected - Description

    • Atenolol tablet, Major, 25 mg, unit-dose blister pack, 100 count, NDC 00904-5392-61

Reason for the Shortage

    • Almatica Pharma has Tenormin tablets available.
    • Mylan, Sandoz, and Teva have atenolol tablets available.
    • Major discontinued atenolol 25 mg unit-dose tablets.
    • Ranbaxy refuses to provide us with any information regarding drug availability.
    • Zydus had atenolol on back order due to increased demand.

Available Products

    • Tenormin tablet, Almatica Pharma, 100 mg, 90 count, NDC 52427-0431-90
    • Tenormin tablet, Almatica Pharma, 25 mg, 90 count, NDC 52427-0429-90
    • Tenormin tablet, Almatica Pharma, 50 mg, 90 count, NDC 52427-0430-90
    • Atenolol tablet, Mylan, 100 mg, unit-dose blister pack, 100 count, NDC 51079-0685-20
    • Atenolol tablet, Mylan, 100 mg, 100 count, NDC 00378-0757-01
    • Atenolol tablet, Mylan, 100 mg, 1000 count, NDC 00378-0757-10
    • Atenolol tablet, Mylan, 25 mg, unit-dose blister pack, 100 count, NDC 51079-0759-20
    • Atenolol tablet, Mylan, 25 mg, 100 count, NDC 00378-0218-01
    • Atenolol tablet, Mylan, 25 mg, 1000 count, NDC 00378-0218-10
    • Atenolol tablet, Mylan, 50 mg, unit-dose blister pack, 100 count, NDC 51079-0684-20
    • Atenolol tablet, Mylan, 50 mg, 100 count, NDC 00378-0231-01
    • Atenolol tablet, Mylan, 50 mg, 1000 count, NDC 00378-0231-10
    • Atenolol tablet, Sandoz, 100 mg, 100 count, NDC 00781-1507-01
    • Atenolol tablet, Sandoz, 100 mg, 1000 count, NDC 00781-1507-10
    • Atenolol tablet, Sandoz, 25 mg, 100 count, NDC 00781-1078-01
    • Atenolol tablet, Sandoz, 25 mg, 1000 count, NDC 00781-1078-10
    • Atenolol tablet, Sandoz, 50 mg, 100 count, NDC 00781-1506-01
    • Atenolol tablet, Sandoz, 50 mg, 1000 count, NDC 00781-1506-10
    • Atenolol tablet, Teva, 100 mg, 100 count, NDC 00093-0753-01
    • Atenolol tablet, Teva, 100 mg, 500 count, NDC 00093-0753-05
    • Atenolol tablet, Teva, 25 mg, 100 count, NDC 00093-0787-01
    • Atenolol tablet, Teva, 25 mg, 1000 count, NDC 00093-0787-10
    • Atenolol tablet, Teva, 50 mg, 100 count, NDC 00093-0752-01
    • Atenolol tablet, Teva, 50 mg, 1000 count, NDC 00093-0752-10
    • Atenolol tablet, Zydus, 100 mg, 100 count, NDC 68382-0024-01
    • Atenolol tablet, Zydus, 100 mg, 1000 count, NDC 68382-0024-10
    • Atenolol tablet, Zydus, 25 mg, 100 count, NDC 68382-0022-01
    • Atenolol tablet, Zydus, 25 mg, 1000 count, NDC 68382-0022-10
    • Atenolol tablet, Zydus, 50 mg, 100 count, NDC 68382-0023-01
    • Atenolol tablet, Zydus, 50 mg, 1000 count, NDC 68382-0023-10

Updated

Updated September 11, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. Created July 5, 2017 by Elyse MacDonald, PharmD, MS, BCPS. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.